Tower Research Capital LLC (Trc) Chimerix Inc Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Chimerix Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 699 shares of CMRX stock, worth $678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

699

Holding current value

$678

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.87 - $1.05 $608 - $733	699 New	699 $0
Q4 2023 Feb 13, 2024	BUY	$0.9 - $1.06 $7,526 - $8,864	8,363 New	8,363 $8,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $4,046 - $5,665	3,679 Added 21.08%	21,134 $25,000
Q1 2023 May 09, 2023	SELL	$1.19 - $2.09 $9,304 - $16,341	-7,819 Reduced 30.94%	17,455 $22,000
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.35 $31,198 - $43,902	18,682 Added 283.4%	25,274 $47,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.76 $5,808 - $8,856	3,209 Added 94.86%	6,592 $13,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $2,239 - $8,923	-1,671 Reduced 33.06%	3,383 $7,000
Q1 2022 May 12, 2022	SELL	$4.58 - $6.8 $109,521 - $162,608	-23,913 Reduced 82.55%	5,054 $23,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $62,440 - $85,722	-11,939 Reduced 29.19%	28,967 $186,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $165,951 - $244,457	27,938 Added 215.44%	40,906 $253,000
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $41,198 - $53,492	-5,464 Reduced 29.64%	12,968 $104,000
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $30,035 - $70,987	6,310 Added 52.05%	18,432 $178,000
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $112,773 - $251,536	-46,409 Reduced 79.29%	12,122 $59,000
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $109,153 - $176,543	47,458 Added 428.59%	58,531 $146,000
Q2 2020 Aug 13, 2020	BUY	$1.33 - $3.63 $5,814 - $15,870	4,372 Added 65.24%	11,073 $35,000
Q1 2020 May 15, 2020	BUY	$1.27 - $2.33 $8,383 - $15,380	6,601 Added 6601.0%	6,701 $10,000
Q4 2019 Feb 07, 2020	SELL	$1.3 - $2.72 $1,817 - $3,802	-1,398 Reduced 93.32%	100 $0
Q3 2019 Nov 05, 2019	BUY	$1.93 - $4.21 $2,891 - $6,306	1,498 New	1,498 $4,000
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $8,375 - $14,598	-4,679 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $10,480 - $18,248	4,679 New	4,679 $12,000
Q3 2018 Nov 13, 2018	SELL	$3.58 - $4.9 $4,163 - $5,698	-1,163 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$4.43 - $5.14 $5,152 - $5,977	1,163 New	1,163 $6,000
Q1 2018 May 15, 2018	SELL	$4.65 - $5.9 $54,511 - $69,165	-11,723 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.32 - $5.52 $20,532 - $26,236	4,753 Added 68.19%	11,723 $54,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $30,319 - $36,592	6,970	6,970 $37,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Chimerix Inc Transaction History